Navigation Links
IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors
Date:7/9/2009

HOUSTON, July 9 /PRNewswire/ -- IDEV Technologies, Incorporated, (IDEV) an emerging leader in the development and marketing of minimally invasive medical technologies, today announced the appointment of veteran medical device executive Rick Anderson to Chairman of its Board of Directors. Thomas M. Tully, the former Chairman and CEO, has retired.

Mr. Tully spent nearly four years as CEO and established a strong, highly differentiated technology platform. Mr. Tully also led the company's effort in launching the FDA-approved SUPERB (Comparison of the SUPERA PERipheral System to a Performance Goal Derived from Balloon Angioplasty Clinical Trials in the Superficial Femoral Artery) IDE study. IDEV's SUPERA stent is a novel platform designed for the treatment of biliary and peripheral artery disease in the superficial femoral artery.

"Tom was instrumental in building the foundation of what is a very fast-growing and prosperous business at IDEV," said President and Chief Operating Officer Christopher M. Owens, who will oversee the day-to-day operations of IDEV. "On behalf of the entire Board and everyone at IDEV, we'd like to thank Tom for his leadership, his years of service and other numerous contributions to the Company."

Mr. Anderson is Managing Director of Austin, TX-based PTV Sciences, a healthcare venture capital and growth equity firm. Prior to PTV Sciences, Mr. Anderson served as Company Group Chairman, Johnson & Johnson, and Worldwide Franchise Chairman, Cordis Corporation.

"We are delighted to have Rick join the company and believe his operating experience and strategic insight will be important additions to our organization," Owens said. "In particular, his expertise in the global stent business will add tremendous value as we continue to expand our product portfolio and enroll new patients in our multi-center clinical SUPERB IDE trial."

Mr. Anderson commented: "I am impressed by the potential of IDEV and its SUPERA stent, which is designed to address the unmet needs of millions of patients who suffer from biliary and peripheral vascular disease. This is a strong company with tremendous growth prospects, and I look forward to working with the management team and Board of Directors at IDEV."

About IDEV Technologies, Incorporated

IDEV Technologies, Incorporated (IDEV) is an innovator and developer of next generation medical devices for use in the interventional radiology, vascular surgery and cardiology device marketplace. IDEV is based in Houston, Texas.

    Contact:  Christopher M. Owens, President and COO
              John Dame, Vice President of Finance
              IDEV Technologies Inc.
              (281) 333-1998


'/>"/>
SOURCE IDEV Technologies, Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BioSpecifics Technologies Corp. Added to Russell 3000 and Russell 2000 Indexes
2. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
3. Greenway Medical Technologies To Display Live Interoperability Implementations at 2009 DIA Show
4. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
5. Wound Management Technologies, Inc. Announced Today That It Has Reached an Agreement in Principal to Acquire BioPharma Management Technologies, Inc.
6. MedNet Solutions to Introduce New EDC/eClinical Technologies at the 2009 Drug Information Association Annual Meeting
7. BioStorage Technologies Takes Lead Sponsorship Role of 2nd Annual IIR Biorepositories Conference
8. A-WIT Technologies Releases World's First Low Cost C Stamp(TM) Based Biotechnology Laboratory in a Box
9. Senesco Technologies, Inc. Announces the Appointment of Dr. Harlan W. Waksal, M.D. as Chairman of the Board of Directors and the Addition of Mr. Warren J. Isabelle, CFA to its Board of Directors
10. Angiotech Enters License, Distribution and Supply Agreements for Fibrin and Thrombin Technologies with Haemacure Corporation
11. AIAA names top ten emerging aerospace technologies of 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 24, 2017  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), ... a Key Opinion Leader event to highlight new clinical ... poster presentation at the upcoming 2017 ASCO-SITC Immuno-Oncology Symposium ... will be held in-person and via live webcast on ... AM PST at the Lotte New York Palace Hotel ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced today ... two key immunotherapy technologies from the University of ... a method to monitor a patient for response ... and CTLA-4.  The second license extends the technology ... is likely to have an immune-related adverse event ...
(Date:2/23/2017)... (PRWEB) , ... February 23, ... ... Inc., announced today that in a published evaluation of multiple immunoassay-based threat ... U.S. Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was ...
(Date:2/23/2017)... , Feb. 23, 2017 Aviva Systems ... announced the acquisition of GenWay Biotech Incorporated, a ... service and product offering for both the research ... facilitate growth and enhance capabilities for both entities. GenWay,s ... ELISA assays will nicely complement ASB,s objective to ...
Breaking Biology Technology:
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a community ... that it has received Laboratory Accreditation from the ... is presented to laboratories that meet stringent requirements ... scientifically rigorous processes. "Genos is committed ... laboratory practices. We,re honored to be receiving CAP ...
(Date:2/10/2017)... 10, 2017 Research and Markets ... "Personalized Medicine - Scientific and Commercial Aspects" to their ... ... is integrated with therapy for selection of treatment as well ... and prevention of disease in modern medicine. Biochip/microarray technologies and ...
(Date:2/8/2017)... Report Highlights ... The global synthetic-biology market reached nearly $3.9 billion in ... a compound annual growth rate (CAGR) of 24.0% through 2021. ... for synthetic biology. - Analyses of global market trends, with ... annual growth rates (CAGRs) through 2021. - Coverage of core ...
Breaking Biology News(10 mins):